The entire platform of interbody products from Tyber Medical has been accepted into the Australian Registry of Therapeutic Goods.
According to a Tyber Medical press release, Therapeutic Goods Administration approval—along with product reimbursement codes—ensures straightforward access to products in the Australian marked. Tyber Medical’s private label partners plan to begin launching products for this market in the third quarter of 2016.
“We expect that access to the Australian market will increase our growth trajectory and allow our private label partners a rapid pathway into the Australian market,” says Tyber Medical chief executive officer, Jeff Tyber.
In the near future, Tyber plans to seek registration for its extremity line of products.